Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

pancreatic cancer

  • Open Access
    The Effect of Asparagus Extract on Pancreatic Cancer: An Intriguing Surprise
    HUAPING XIAO, ZULIANG DENG, JACOB T. HOUGH, XUHUI CHEN, ZIWEN ZHU, JACOB LEE, ALDO DOMINGUEZ, TIANRU SHI, JOSEPH SCHMIDT, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research May 2022, 42 (5) 2425-2432; DOI: https://doi.org/10.21873/anticanres.15721
  • Open Access
    Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
    YUTARO KUBOTA, QINGHONG HAN, CHIHIRO HOZUMI, NORIYUKI MASAKI, JUN YAMAMOTO, YUSUKE AOKI, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Anticancer Research May 2022, 42 (5) 2567-2572; DOI: https://doi.org/10.21873/anticanres.15734
  • You have access
    Elevated Preoperative DUPAN-2 Level Predicts Locoregional Recurrence After Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma
    ATSUSHI SASAKI, SHOICHI INOKUCHI, SATOSHI TSUTSUMI, TAKURO FUTSUKAICHI, TAKAHIRO TERASHI, MASAHIKO IKEBE, TOSHIO BANDOH and TOHRU UTSUNOMIYA
    Anticancer Research April 2022, 42 (4) 2071-2078; DOI: https://doi.org/10.21873/anticanres.15688
  • You have access
    The Nitrated Form of Nateglinide Induces Apoptosis in Human Pancreatic Cancer Cells Through a Caspase-dependent Mechanism
    KOJI NISHI, SHUHEI IMOTO, TAKURO BEPPU, SHOTARO UCHIBORI, AYANA YANO, YU ISHIMA, TOKUNORI IKEDA, KENJI TSUKIGAWA, MASAKI OTAGIRI and KEISHI YAMASAKI
    Anticancer Research March 2022, 42 (3) 1333-1338; DOI: https://doi.org/10.21873/anticanres.15601
  • You have access
    Republication: A Prospective Observational Study of Adoptive Immunotherapy for Cancer Using Zoledronate-Activated Killer (ZAK) Cells – An Analysis for Patients With Incurable Pancreatic Cancer
    YOSHIYUKI YAMAGUCHI, YOUSUKE KATATA, MAKOTO OKAWAKI, AKIRA SAWAKI and MASAHIRO YAMAMURA
    Anticancer Research February 2022, 42 (2) 1181-1187; DOI: https://doi.org/10.21873/anticanres.15584
  • You have access
    A Systematic Review of Minimally Invasive Versus Open Radical Antegrade Modular Pancreatosplenectomy for Pancreatic Cancer
    KOSEI TAKAGI, YUZO UMEDA, RYUICHI YOSHIDA, TAKAHITO YAGI and TOSHIYOSHI FUJIWARA
    Anticancer Research February 2022, 42 (2) 653-660; DOI: https://doi.org/10.21873/anticanres.15523
  • You have access
    High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model
    NORIHIKO SUGISAWA, KENTARO MIYAKE, TAKASHI HIGUCHI, HIROMICHI OSHIRO, JUN HO PARK, KEI KAWAGUCHI, MICHAEL BOUVET, MICHIAKI UNNO and ROBERT M. HOFFMAN
    Anticancer Research February 2022, 42 (2) 739-743; DOI: https://doi.org/10.21873/anticanres.15532
  • You have access
    Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study
    AKIKO TODAKA, SATOSHI NARA, FUYUHIKO MOTOI, SOICHIRO MORINAGA, REISHI TOSHIYAMA, RYOTA HIGUCHI, MASARU KONISHI, HIROFUMI SHIRAKAWA, HIDETAKA TSUMURA, HIROYUKI OKUYAMA, HIROAKI NAGANO, KAZUHIKO SHIOJI, KEISHI SUGIMACHI, AKINORI ASAGI, NOBUMASA MIZUNO and JUNJI FURUSE
    Anticancer Research February 2022, 42 (2) 893-902; DOI: https://doi.org/10.21873/anticanres.15547
  • You have access
    The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death
    JAN-PHILIPP RUFF, ANNA-LAURA KRETZ, MARKO KORNMANN, DORIS HENNE-BRUNS, JOHANNES LEMKE and BENNO TRAUB
    Anticancer Research December 2021, 41 (12) 5973-5985; DOI: https://doi.org/10.21873/anticanres.15416
  • You have access
    Intravenous Administration of Dehydroxymethylepoxyquinomicin With Polymer Enhances the Inhibition of Pancreatic Carcinoma Growth in Mice
    HIROTO FUJISAKI, YUTAKA NAKANO, SACHIKO MATSUDA, KEIICHI SUZUKI, OSAMU ITANO, MASAYUKI TANAKA, SHUTARO HORI, YASUSHI HASEGAWA, YUTA ABE, HIROSHI YAGI, MINORU KITAGO, TOMOHIRO KONNO, KAZUHIKO ISHIHARA, KEIKO OHNO, SATOSHI KISHINO, KAZUO UMEZAWA and YUKO KITAGAWA
    Anticancer Research December 2021, 41 (12) 6003-6012; DOI: https://doi.org/10.21873/anticanres.15419

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 18
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire